Severe amyloid deposition in mammary glands of familial amyloid polyneuropathy patients

References

• Ikeda S, Nakazato M, Ando Y, Sobue G. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Neurology 2002; 58: 1001–1007
   PubMed Web of Science ®Google Scholar
• Connors L H, Lim A, Prokaeva T, Roskens V A, Costello C E. Tabulation of human transthyretin (TTR) variants, 2003. Amyloid: J Protein Folding Disord 2003; 10: 160–184
   PubMed Web of Science ®Google Scholar
• Misu K, Hattori N, Nagamatsu M, Ikeda S, Ando Y, Nakazato M, Takei Y, Hanyu N, Usui Y, Tanaka F, Harada T, Inukai A, Hashizume Y, Sobue G. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features. Brain 1999; 122: 1951–1962
   PubMed Web of Science ®Google Scholar
• Koike H, Misu K, Ikeda S, Ando Y, Nakazato M, Ando E, Yamamoto M, Hattori N, Sobue G, for the Study Group for Hereditary Neuropathy in Japan. Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan. Early- vs late-onset form. Arch Neurol 2002; 59: 1771–1776
   PubMed Web of Science ®Google Scholar
• Sousa A, Coelho T, Lobato L, Sequeiros J. Parental transmission and anticipation of age-of-onset in FAP-I. Am J Hum Genet 1991; 49(Suppl.)A2757
   Google Scholar
• Drugge U, Andersson R, Chizari F, Danielsson M, Holmgren G, Sandgren O, Sousa A. Familial amyloidotic polyneuropathy in Sweden: a pedigree analysis. J Med Genet 1993; 30: 388–392
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Ikeda S, Hanyu N, Takeda S, Yanagisawa N. A pedigree analysis with minimized ascertainment bias shows anticipation in Met30-transthyretin related familial amyloid polyneuropathy. J Med Genet 1998; 35: 23–30
   PubMed Web of Science ®Google Scholar
• Soares M, Buxbaum J, Sirugo G, Coelho T, Sousa A, Kastner D, Saraiva M J. Genetic anticipation in Portuguese kindreds with familial amyloidotic polyneuropathy is unlikely to be caused by triplet repeat expansions. Hum Genet 1999; 104: 480–485
   PubMed Web of Science ®Google Scholar
• Soares M L, Coelho T, Sousa A, Batalov S, Conceição I, Sales-Luis M L, Ritchie M D, Williams S M, Nievergelt C M, Schrk N J, Saraiva M J, Buxbaum J N. Susceptibility and modifier genes in Portuguese transthyretin V30M amyloid polyneuropathy: complexity in a single-gene disease. Hum Mol Genet 2005; 14: 1–11
   PubMedGoogle Scholar
• Xing Y, Nakamura A, Chiba T, Kogishi K, Matsushita T, Fu L, Guo Z, Hosokawa M, Mori M, Higuchi K. Transmission of mouse senile amyloidosis. Lab Invest 2001; 81: 493–499
   PubMed Web of Science ®Google Scholar
• Lundmark K, Westermark G T, Nyström S, Murphy C L, Solomon A, Westermark P. Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc Natl Acad Sci USA 2002; 99: 6979–6984
   PubMed Web of Science ®Google Scholar
• Cui D, Kawano H, Takahashi M, Hoshii Y, Setoguchi M, Gondo T, Ishihara T. Acceleration of murine AA amyloidosis by oral administration of amyloid fibrils extracted from different species. Pathol Int 2002; 52: 40–45
   PubMed Web of Science ®Google Scholar
• Fu X, Korenaga T, Fu L, Xing Y, Guo Z, Matsushita T, Hosokawa M, Naiki H, Baba S, Kawata Y, Ikeda S, Ishihara T, Mori M, Higuchi K. Induction of AApoAII amyloidosis by various heterogeneous amyloid fibrils. FEBS Lett 2004; 563: 179–184
   PubMedGoogle Scholar
• Korenaga T, Yan J, Sawashita J, Matsushita T, Naiki H, Hosokawa M, Mori M, Higuchi K, Fu X. Transmission of amyloidosis in offspring of mice with AApoAII amyloidosis. Am J Pathol 2005; 168: 898–906
   Google Scholar
• Prusiner S B. Genetic and infectious prion diseases. Arch Neurol 1993; 50: 1129–1153
   PubMedGoogle Scholar
• Hill A F, Desbruslais M, Joiner S, Sidle K C, Gowland I, Collinge J, Doey L J, Lantos P. The same prion strain causes vCJD and BSE. Nature 1997; 389: 448–450
   PubMed Web of Science ®Google Scholar
• Ikeda S, Hanyu N, Hongo M, Yoshioka J, Oguchi H, Yanagisawa N, Kobayashi T, Tsukagoshi H, Ito N, Yokota T. Hereditary generalized amyloidosis with polyneuropathy. Clinicopathological study of 65 Japanese patients. Brain 1987; 110: 315–337
   PubMed Web of Science ®Google Scholar
• Tachibana N, Tokuda T, Yoshida K, Taketomi T, Nakazato M, Li Y -F, Masuda Y, Ikeda S. Usefulness of MALD-TOF mass spectrometry of immunoprecipitated serum variant transthyretin in the diagnosis of familial amyloid polyneuropathy. Amyloid: Int J Exp Clin Invest 1999; 6: 282–288
   PubMed Web of Science ®Google Scholar
• Hoshii Y, Setoguchi M, Iwata T, Ueda J, Cui D, Kawano H, Gondo T, Takahashi M, Ishihara T. Useful polyclonal antibodies against synthetic peptides corresponding to immunoglobulin light chain constant region for immunohistochemical detection of immunoglobulin light chain amyloidosis. Pathol Int 2001; 51: 264–270
   PubMed Web of Science ®Google Scholar
• Rubinow A, Koff R S, Cohen A S. Skin involvement in generalized amyloidosis: a study of clinically involved and uninvolved skin in 50 patients with primary and secondary amyloidosis. Ann Intern Med 1978; 88: 781–785
   PubMed Web of Science ®Google Scholar
• Rubinow A, Cohen A S. Skin involvement in familial amyloidotic polyneuropathy. Neurology 1981; 31: 1341–1345
   PubMed Web of Science ®Google Scholar
• Maruyama K, Ikeda S, Yanagisawa N, Nakazato M. Diagnostic value of abdominal fat tissue aspirate in familial amyloid polyneuropathy. J Neurol Sci 1987; 81: 11–18
   PubMed Web of Science ®Google Scholar
• Axelrad M A, Kisilevsky R, Willmer J, Chen S J, Skinner M. Further characterization of amyloid-enhancing factor. Lab Invest 1982; 47: 139–146
   PubMed Web of Science ®Google Scholar
• Yokota T, Ishihara T, Kawano H, Takahashi M, Fujinaga Y. Amyloid enhancing factor (AEF) in the aging mouse. Virchows Archiv (A) Pathol Anat 1989; 414: 511–514
   PubMedGoogle Scholar
• Johan K, Westermark G, Engström U, Gustavsson A, Hultman P, Westermark P. Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils. Proc Natl Acad Sci USA 1998; 95: 2558–2563
   PubMed Web of Science ®Google Scholar
• Glenner G G. Amyloid deposits and amyloidosis: the β-fibrilloses. N Engl J Med 1980; 302: 1283–1292
   PubMed Web of Science ®Google Scholar
• Jarret J T, Lansbury P T, Jr. Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?. Cell 1993; 73: 1055–1058
   PubMedGoogle Scholar
• Caughey B. Transmissible spongiform encephalopathies, amyloidoses and yeast prions: common threads?. Nat Med 2000; 6: 751–754
   PubMedGoogle Scholar
• Gadjusek D C. Spontaneous generation of infectious nucleating amyloids in transmissible and non-transmissible cerebral amyloidoses. Mol Neurobiol 1994; 8: 1–13
   Web of Science ®Google Scholar
• Cathcart E S, Elliott-Bryant R. Diet, amyloid enhancing factor (AEF) and amyloidogenesis: hypothesis. Amyloid: Int J Exp Clin Invest 1999; 6: 107–113
   PubMed Web of Science ®Google Scholar
• Lundmark K, Westermark G T, Olsén A, Westermark P. Protein fibrils in nature can enhance amyloid protein A amyloidosis in mice: cross-seeding as a disease mechanism. Proc Natl Acad Sci USA 2005; 102: 6098–6102
   PubMed Web of Science ®Google Scholar
• Tojo K, Tokuda T, Hoshii Y, Fu X, Higuchi K, Matsui T, Kametani F, Ikeda S. Unexpectedly high incidence of visceral AA-amyloidosis in slaughtered cattle in Japan. Amyloid: J Protein Folding Disord 2005; 12: 103–108
   PubMed Web of Science ®Google Scholar
• Ligios C, Sigurdson C J, Santucciu C, Carcassola G, Manco G, Basagni M, Maestrale C, Cancedda M G, Madau L, Aguzzi A. PrPsc in mammary glands of sheep affected by scrapie and mastitis. Nat Med 2005; 11: 1137–1138
   PubMed Web of Science ®Google Scholar
• Pitelka D R. The mammary gland. Histology4th ed, L Weiss, R O Greep. McGraw-Hill, New York 1977; 925–950
   Google Scholar
• Tagoe C E, French D, Gallo G, Buxbaum J N. Amyloidogenesis is neither accelerated nor enhanced by injections of preformed fibrils in mice transgenic for wild-type human transthyretin: the question of infectivity. Amyloid: J Protein Folding Disord 2004; 11: 21–26
   PubMed Web of Science ®Google Scholar
• Wei L, Kawano H, Fu X, Cui D, Ito S, Yamamura K, Ishihara T, Tokuda T, Higuchi K, Maeda S. Deposition of transthyretin amyloid is not accelerated by the same amyloid in vivo. Amyloid: J Protein Folding Disord 2004; 11: 113–120
   PubMed Web of Science ®Google Scholar